Showing results (561-570 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|April 28, 2026
Subcutaneous foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's disease (aPD): societal cost impact analysis for the UK, France, Germany, Spain, and CanadaK Ray Chaudhuri, Juan Carlos Parra, Trishal Boodhna, et al.Journal of Medical Economics|April 22, 2026
Value frameworks for digital health technologies: a comparative analysisBriana M Choi, Jeannie K Lee, Brian Erstad, et al.Journal of Medical Economics|April 25, 2026
Cost-effectiveness analysis of atezolizumab and bevacizumab as first-line systemic therapy in unresectable hepatocellular carcinoma in MalaysiaYoke Fui Wong, Rosmawati Mohamed, Audi Adawiah Sulaiman Shah, et al.Journal of Medical Economics|May 9, 2026
Cost-effectiveness analysis of xanomeline and trospium chloride for the treatment of adults with schizophrenia in the USTyler Mantaian, Kristin Gillard, Jonathan Kowalski, et al.Journal of Medical Economics|May 13, 2026
CPAP treatment persistence following nasal procedures in obstructive sleep apnea: a real-world claims-based analysis of 1.3 million patientsAtul Malhotra, Mas Takashima, Andrew Vahabzadeh-Hagh, et al.Journal of Medical Economics|November 16, 2018
Societal preferences for fertility treatment in Australia: a stated preference discrete choice experimentWillings Botha, Natasha Donnolley, Marian Shanahan, et al.Journal of Medical Economics|May 22, 2026
A systematic review of acute and long-term outcomes in patients with non-transvenous implantable cardioverter-defibrillatorsSteven Zweibel, David Lanctin, Reece Holbrook, et al.Journal of Medical Economics|June 8, 2026
Modeling the cost-effectiveness of the COVID-19 mRNA-1273 vaccine in the United StatesKelly Fust, Ekkehard Beck, Michele Kohli, et al.Journal of Medical Economics|June 8, 2026
A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspectiveVarun Ektare, Claire Simons, Kasper Johannesen, et al.Journal of Medical Economics|June 12, 2026
Cost-consequence analysis of diagnostic strategies for suspected community-acquired pneumonia in France and SpainOleg Borisenko, Jeroen I Stas, Andrey Maslov, et al.Pageof 241